“ADHERENCE TO TREATMENT: GLOBAL CHALLENGE, TANGIBLE SOLUTIONS”

Significant problems with adherence persist across geographies and therapy areas, leading to non-optimal care and delays in recovery1.  Aside from continuous progress in healthcare technologies and the regular launch of new medicines every year, according to the WHO, the most effective intervention to improve the health of the overall population is to increase adherence to treatments2.

Adherence has traditionally been framed as a problem of patient understanding, and even memory (as patients are thought to simply “forget” their treatment).  But what if this belief ignores the real issues and reinforces misconceptions? Approximately 25% of patients after being discharged from hospital stop some of their treatment within the first week.  This signals that the problem isn’t simply memory but is rooted in deeper behavioral and societal factors3.

At the a:care Congress 2022, you will learn:

  • About the pervasive myths that hide the true drivers of non-adherence
  • How to shift the paradigm and treat the person, not just the disease
  • How patients understand adherence, and how their insights can be used in clinical practice

The Congress will combine global sessions, which will be held in English, with local sessions that will look at specific local drivers of non-adherence and discuss tailored solutions specific to this region.

THE A:CARE VIRTUAL CONGRESS HAS CONCLUDED. CLICK HERE FOR RECORDINGS.

Programs

An exciting and innovative congress program.

The congress will address the common misconceptions with regards to adherence and take a deeper look at the underlying drivers behind non-adherence. Through a two-day agenda of presentations and panel discussions the a:care congress will equip you with the tools to address non-adherence through theory-driven, evidence-based behavioral interventions.

Speakers

A diverse faculty of behavioral scientists, clinicians and patients.

Chaired by Prof John Weinman, Professor of Psychology at King’s College London and Dr. Shashank Joshi, Padma Shri Professor from India, the congress features sessions from international clinical experts across multiple therapy areas. The congress will feature patient voice sessions to hear from individuals who struggled with adherence and can provide a first-person perspective on the specific challenges they faced.


This is a tentative agenda and may be subject to change. Abbott does not guarantee the attendance of the announced speakers and disclaims any responsibility for potential speaker cancellations or other changes to the agenda.

References

1. Jose J, Bond C. Medication Adherence: still a problem. Int J Pharm Practice. 2021;29(2):93-95. doi:10.1093/ijpp/riaa019

2. Brown MT, Bussell JK. Medication adherence: WHO cares?. Mayo Clin Proc. 2011;86(4):304-314. doi:10.4065/mcp.2010.0575

3. Fallis BA, Dhalla IA, Klemensberg J, Bell CM. Primary Medication Non-Adherence after Discharge from a General Internal Medicine Service. PLOS ONE. 2013;8(5):e61735. https://doi.org/10.1371/journal.pone.0061735.


Endorsed by